Winning
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
20100819|POSC|3099218|6387337|O
Wow. 48% short interest today.
I think we established a solid support level at .08.
At this point, if over 3 million shares sold short couldn't keep it under, nothing will. Let em keep trying to do it though. It'll just make the squeeze all the more fun to watch.
Likely scenario, in my sole opinion. Post limited PR about partnership a couple days before quarter 10Q. Limited to the point to where some investors decide it's not enough so they sell or short. Bring the price down to see where support lies with the fresh news. Once support is firmly established, start buying on the cheap and then start posting additional PRs creating doubt among shorts. Be fully loaded by quarter announcement where 'forward looking statement predicts amazing things, causing shorts to cover and others to jump in.
How better to maximize results from specific events then to create a bit of uncertainty and then erase it. Regardless of product, this is still a penny stock and sharks still swim the ocean and play games. Of course, companies are legally bound to rules when it comes to purchasing their own stock around announcements, but they all have friends who aren't. Luckily, I believe I'm on the same side as the sharks as are most of the people that are holding. We should make some decent coin on this when all is said and done.
I could be wrong of course. As I said, this is still a penny stock. Major companies usually won't invest a lot of money into a partnership with a company whose still on the OTC BB, and if that company is not positioning themselves to get off of the OTC BB and into a major index. So, the biggest news I believe POSC can make is a move off of the OTCBB and into a major index,or at least be in a position to do so. In order to be in any position they must have the ability to do a reverse stock slit as required by indexes and that can only happen if approved by major shareholders. Only then will they be taken seriously. So, Coviden might just be taking things slowly and this will be a process that matures over time into something great.
Either way, its a good investment. I'm not going to play the daytrading thing with this. I'll just hold and watch things unfold as they may. I got time.
Whether or not they go to triple zeros, is riding on whether or not they get a Turbine Licensing agreement with Venco Power and whether or not the patent office gives them a patent for their S322 & S594 Small Vertical Axis Wind Turbines, which is supposed to happen this fall. Until that news comes out, we will not see triple zeros nor a price over .01.
Info on Fred Frank: The person named in the conference call whom is helping NWCI find strategic partners.
Frederick Frank is Vice Chairman of the Peter J. Solomon Company, and was Vice Chairman of Barclays Capital.
He was Vice Chairman and Director at Lehman Brothers, which was acquired by Barclays in September 2008 and which he joined as a Partner in October 1969.
Before Lehman, he was Co-Director of Research and Vice President and Director of Smith, Barney & Co.
He is a Chartered Financial Analyst, member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts.
He is a member of the advisory boards of the Pharmaceutical Executive Magazine and the Journal of Life Sciences.
He is the past Chairman of the Board of the Irvington Institute for
Immunological Research.
He formerly served on the Advisory Board of The Harvard School of Public Health, the Johns Hopkins Bloomberg School of
Public Health and the Massachusetts Institute of Technology Center for Biomedical Innovation.
He is also a former director and Chairman of the Board of Epix Pharmaceuticals, Inc., as well as the Irvington Institute for Immunological Research.
He is also Director of Diagnostic Products, Pharmaceutical Products Development, Landec Corporation and Predix Pharmaceuticals.
He serves on the Yale School of
Management Advisory Board.
True. Even with the downward movement, most of it is due to basic short selling. Roughly 35-40% short interest this week alone. I'd rather see that then see people just blatantly selling off their shares. At least shorts have to cover eventually.
It all comes down to Rooney. He's either full of BS or he isn't.
That's what shorts are betting on.
Although his history has shown he is capable of misleading investors, which provides fuel for the Shorts, I believe he is legit on this one.
I don't think he is dumb enough to repeat history. When I talked to a SEC Rep before the Nasdaq Market announcement, he said everything looked legit with the company and with Rooney. He's on their radar. He knows it to. Everything will be by the book on this. He already messed up bigtime by talking to biomedreports. I doubt he'll make another ill planned move.
Additionally, this stock is loaded with people with their fingers on the 'sell trigger'. People that would rather make a quick $100 in one day rather than a $1000 in 2 days, so to speak. Logical? No. But that's the OTC for you. It'll take massive and sustained volume to get this back past .16 and keep it past .16
It'll happen when it happens.
Some Notable Presentations Over The Past Year:
1. Dr. Ihor Gussak chaired the automated cardiac safety solution segment of the Cardiac Safety Vendor Workshop in London. The segment featured a Who’s Who in the cardiac safety industry focusing on the market adoption of the automated solution. Here, FDA representatives reinforced their support of the use of automated solutions in TQT studies.
2. Dr. Sam George, Senior Medical Consultant, joined a distinguished roster of speakers, moderators and panelists at the Cardiac Safety Research Consortium (CSRC) annual meeting in October.
3. They presented two abstracts and discussed new clinical data from analytical and clinical applications of their proprietary platform technology at The Heart Rhythm Society (HRS) 30th Annual Scientific Sessions.
4. At the DIA Cardiovascular Safety and QT/Arrhythmia Assessment in Drug Development - Optimizing Drug Development Conference, co-sponsored by the FDA and the HRS, they presented their technology and clinical validation results along with their primary automatic solution competitors.
5. NewCardio, Inc. Presented at the 2nd Annual LD MICRO Conference in Los Angeles. LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space.
6. NewCardio, Inc. to Present at the One Med Forum 2010 Emerging Company Finance Conference. The One Med Place Finance Forum was created to connect emerging healthcare and life science companies with investors and strategic partners.
7. NewCardio's Chief Medical Officer, Dr. Ihor Gussak, presented at the Prestigious Cardiac Electrophysiology Conference in Tokyo. The J-IVFS is one of the most prestigious Cardiac Electrophysiology events in the world, covering areas of particular focus in Japan where idiopathic sudden cardiac arrest is endemic and very problematic.
8. The Heart Rhythm Society (HRS) has accepted an abstract detailing the superior performance of NewCardio's patented CardioBip™ technology for remote wireless monitoring and detection of atrial fibrillation (AF).
9. Two of NWCI’s most recent medical and technical submissions have been accepted for presentation at the prestigious 15th Annual World Congress on Heart Disease to be held in Vancouver BC. The Company will present data from both the advanced coronary artery disease (CAD) and atrial fibrillation (AF) clinical studies, with additional information from ongoing CardioBip™ clinical studies. The data supports CardioBip’s suitability for long-term monitoring of patients with CAD and AF.
10. NWCI unveiled its patented CardioBip™ technology for remote wireless 12-lead detection and monitoring of atrial fibrillation, ischemia and other cardiovascular events at the Heart Rhythm Society (HRS) 31st Annual Scientific Sessions.
11. Five of its most recent medical and technical submissions have been accepted for publication in prominent peer-reviewed medical journals. These publications will present important clinical data supporting the accuracy and effectiveness of its CardioBip™ and Cardio3KG™ products.
12. Two of its recent medical and technical submissions have been accepted for presentation at the 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society conference. The two papers: “Wireless Transmission of Reconstructed 12-Lead ECGs in the Remote Monitoring of Atrial Fibrillation” and “Wireless Remote Monitoring of Myocardial Ischemia Using Reconstructed 12-Lead ECGs” will be presented during the conference to be held August 31st through September 4th, 2010, in Buenos Aires, Argentina.
Some notable commercialization-related achievements over the last year:
With the recent downward movement of the PPS, lets not lose sight of the big picture. Given time and patience, it's true valuation will be represented. This company is definitely worth more than what it is listed at today. Short sellers have brought it down, with 43% of all trades in July being short.
These are some of the MSAs and such, over the last year that were signed with NWCI for it's 1st product, QTinno.
1. A top-five pharmaceutical company named QTinno as the technology that will be used in all of its fully automated TQT studies. This pharmaceutical company evaluated several automated cardiac safety solutions before choosing QTinno.
2. A Master Services Agreement (MSA) was signed with a top-three Clinical Research Organization (CRO), which will use QTinno as their technology in fully automated Phase I TQT studies delivered by their centralized ECG core lab.
3. A top-five CRO also signed an MSA with NWCI, licensing QTinno in all TQT studies where fully automated readings are obtained.
4. Dedicated Phase I, an innovative provider of clinical research services signed an MSA, licensing QTinno software solution in all TQT studies where fully automated readings are obtained.
5. NewCardio Signed another Master Services Agreement (MSA) with U.S.-Based Contract Research Organization (CRO) for Qtinno. In addition, the CRO has signed a services work order, including standard operating procedures (SOP) and validation kits, as well as professional services, in order to accelerate its readiness for delivering ECG core lab services to its sponsor customers.
6. Clinilabs Signs MSA with NewCardio, Inc. for Qtinno. NewCardio to Perform First Revenue-Generating QT Study Using Qtinno. Master Services Agreement Enables Clinilabs to Add ECG Core Lab Services, Extending its Scope of Services and Capturing Additional Revenue.
7. A leading global biopharmaceutical services provider has signed a MSA, licensing NewCardio's QTinno™ software solution to enhance its delivery of fully automated cardiac safety analyses for early phase QT studies. The CRO is expected to deploy QTinno in several clinical unit locations worldwide. In addition, the CRO has signed a services work order related to the first study using QTinno.
Dana Resources expected to report Fiscal Year 2010 results on October 14, 2010. This event was calculated by Capital IQ (Created on June 27, 2010).
http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DANR:US
Some of you are making this more complicated than it really is.
Simply put, the whole market is hurting right now. Investors are pulling out of riskier investments. That's the reason for the slight decrease in pps. When positive news hits, the risk will decrease, buying volume will increase. Rooney or any other exec., doesn't give a rat's ass about any investor on this board. Half of you are penny flippers anyways. They worry more about institutional investors, etc, and those guys/gals are sitting patient. They will release partnership/alliance news when they want to, not when we want them to.
They're not going to make dinky little PR's to soothe the nerves of investors on message boards. They already dug themselves a hole by talking to BMR. Why make that hole deeper?
I don't trust Rooney as far as I can throw him. However, the fact of the matter is that Rooney has put his ass on the line by making public statements of "inked" partnerships and dramatic increase of revenue. He is now responsible for those statements. With his checkered past, I highly doubt he wants the heat of the SEC on him by stating falsehoods. He'd have to be a complete moron to make all this stuff up. I believe that they will deliver. Not if, but when. All i know is that it won't be on 'our time'.
Obvious manipulation.
With this stock's history of being on the regsho list, the naked shorting, the abnormal friction factors, the complete blackout of info by management, I would actually call this one of the most fun stocks to observe on a daily basis. I'm already sitting on a 94% loss, so I'm at the point where I just don't care anymore. I just want to see how corrupt it can actually get before completely tanking out.
Today is a good example of an abnormal friction factor, where the pps ended 16% down on high buying volume. 2,840,000 to 1,297,00 buy/sell.
I gotta give props to the traders playing on the daily movements. Takes some balls to roll the dice with this one. Tomorrow should be an interesting play as a result of today's behavior.
I know that. There are a ton of reasons why it fell from 3$ to a cent. I'm just saying, if you're going to list a reason for it, list a correct reason. You have plenty to choose from. Why pick the one reason that's incorrect? If there is an insider trade they have to file with the SEC. Plain and simple.
Of all the legitimate things you can bash this stock over, why accuse it of the one thing it's not guilty of. There is no insider selling. Show the the filing with the SEC that shows an insider has been selling. And I don't mean the execs that left the company last March.
It'll be released at an odd time. When least expected. Just like all these things are. Impossible to predict when. I don't think penny flippers will want to sell into the close on this one.
That statement is in every 10Q of every report for every company that has 'Research and Developmental' stage status. I'm not saying everything is fine with this particular company, but if you base your trading strategies with penny stocks off of the risk assessments contained in those releases, you wouldn't own any OTC BB stocks at all.
Why bother even wondering.
I'm getting close to that. -87.88% for me. Its so absurd, I find myself laughing????
Being that this was the worst week for the entire market this year, I think that the general sentiment going into the close was to just stop and take a breath and let everything soak in. Granted the general indexes recovered a bunch in the final 30, I think most investors are not taking any chances going into the weekend. Plus I think for POSC, most investors believe that it'll go back to .10 support next week and will get in then. Right now, Penny flippers are the only ones trading this until solid news is released. Not old news like today. I believe there is no way it sinks below .10 and no way it goes above .145. Daytraders won't let it.
From the 10Q May 20th
The following transactions occurred between April 1, 2010 and May 20, 2010:
The Company issued 35,050,005 shares of common stock to investors for $1,087,000 .
Investors exercised warrants to purchase 56,000,000 shares of common stock for an aggregate purchase prices of $1,120,000.
Investors converted 174,000 shares of Series B Preferred Stock into 17,400,000 shares of the Company’s Common Stock.
Investors converted 15,000 shares of Series G Preferred Stock into 1,500,000 shares of the Company’s Common Stock.
The Company issued 29,150,000 shares common stock for services and recorded consulting fee expense of $3,963,500 for the issuance of these shares.
From what I've seen, this is what the MM's, chiefly NITE, has begun doing to the stock. They tank it. Shake weak hands out. Accumulate. Then shoot it up very quickly. They'll do it again and again until big news occurs as this stock is full of inexperienced investors that sell low as well as ones that short at the bottom.
Correction to that Reg Sho list.
Buyins.net now shows that it was removed from the list on May 13th.
They still show the squeeze at .01
Buyins.net still shows hlxw to be on the Reg Sho list. They have the squeeze set at .01. The biggest problem with this stock is, plain and simply, corrupt trading.
I have faith, but not that much.
I'm long, but only using my gambling money. I may go into my reserves to average down a bit, but I'll wait until we have a bottom established. I'm not yet convinced it's here as the pps is at the mercy of the sharks that are circling it. Management has all but left it out in open water without as much as a life jacket to wear. The latest financing is just a piece of driftwood to hang onto. The question is, how good of a swimmer is it and long can let it tread water. But the fact remains, it's still afloat and I have hope that it will be plucked out of the water eventually.
I hope your gamble pays off. It's ballsy.
Cheers.
Abusive Naked Shorting, in which (a) short sellers sell shares they have not borrowed, and (b) are unable to deliver those shares on the settlement date of their sale, has been occurring with HLXW
Traders are now in violation and hlxw has been placed on the reg sho list. For the 2nd time this year.
http://www.buyins.net/releases/?id=100134
For those that don't know:
Threshold securities are equity securities that have an aggregate fail to deliver position for:
* five consecutive settlement days at a registered clearing agency (e.g., National Securities Clearing Corporation (NSCC))
* totaling 10,000 shares or more; and
* equal to at least 0.5% of the issuer's total shares outstanding.
Short sellers will have to cover soon. It can't stay in the cellar much longer.
Everybody that sold should of known that the short sellers would cover and that there would be a bounce. Never sell on emotion. Most important lesson ever. Congrats are in order for all the shorts. They made the correct play.
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000844985
The last insider trades were in 2006
Indeed...
That was the line that sparked questions with me.
Its also the line that will set him up to fry if he's full of it.
Link to every single POSC filing with SEC
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000844985&owner=exclude&count=40
In regards to accusations the company is selling it's shares.
Its illegal to for a company to buy or sell before an announcement.
Might want to give this a read.
http://www.sec.gov/rules/final/33-7881.htm
Additionally, there has been no insider trading for this stock in a very, very long time. I challenge anybody to dig up a recent form 4 filing made by any executive or other insider.
Look, I don't trust Rooney one single bit. He's extremely shady and corrupt, professionally and morally. That doesn't mean every transaction he does is shady. I don't think he would set himself up for one giant headache. However, earnings is a whole different piece of cake to digest. I won't be around long enough to find out.
Valid point. Refreshing.
Unlike BMR, Rooney has made confirming statements and is now responsible for them. He'll be the one to fry is things go south.
I just wish things would of been handled differently by the parties involved leading into next week. They need to work on their IR. I am hopeful for the best, but do remain a bit cynical. Hopefully, all of my questions are unwarranted everybody will make some good green.
Best of luck to you.
Explain that philosophy
to all of the bag holders in NWCI. BMR's
buyout 'sure thing' miracle pick a couple months ago.
They claimed to have 'sources inside the company' in those articles as well. Everybody was cancelling their subscriptions, threatening lawsuits, etc. The usual message board banter after a 'burn'.
BMR will never be in a short supply of subscribers. To use that as a gauge of whether or not they'll make right or wrong pick is flawed.
For ever failed prediction they do have, there are ones that work out as well. For every angry investor, there is a happy one. Perhaps this is one of the right picks. I hope so because I'm invested in it. Not a lot. But, for now, enough. :)
When something looks like a sure thing, it often isn't.
I have zero trust when it comes to these pumping sites.
Goes down a little on Monday. I like the .17 prediction. Then a bounce back up to .25 resistance where it will close. Tuesday as the .25 resistance gets broken, there will be a bear raid as shorts will start pinning the bid and that will take it back down to somewhere under .20 Then the last half hour, volume will pick up and we'll see a ton of frenzied buying and investors locking in profits until news is released. We close Tuesday at .24 Wednesday, buying increases in the morning up until the news release. .25 resistance will be broken and by 10am it'll be at .30. Then depending on the news, being that most of the news is already factored into the pps from the pre mature releases, it needs to be extraordinary, or the whole' buy on rumor, sell on the news' traders will bring it down. If the news is mind blowing, we might see a close over .50. I really have no clue. A penny stock is a penny stock after all :) Good luck to all.
"Many of life's
failures are men who did not realize how close they were to success when they gave up."
Thomas Edison
Nothing is really going up today with all the GS shenanigans and what not.
Let people here get scarred,take their losses and move on.
It'll go back up eventually. Until then, I'll just continue to average down. I'm looking to the summer when electricity
demand once again goes though the roof, electric bills shoot up, and rolling blackouts start occurring. Attention will then, again, turn back to alternate forms of energy and interest in affordable wind turbines will start to increase.
One never knows whats around the next bend, when on such a curvy road that is Helix. Stranger things have happened. It would be a pleasant development, that's for sure. Then again, any development would be nice at this point.
Wasn't the deal with Venco terminated in March being that it didn't have the financing? Why do you think it will happen again?
Yeah, it held .10 very well. There were a few nice blocks in there when it was needed. All and all frustration reigns supreme for me.
Not just with Helix but with my entire portfolio. Mama said there would be weeks like this. Thank god for my playoff hockey tickets tonight. Maybe the Kings will give me something to cheer about.
So much for the 'Hammer' yesterday
Short Squeeze Trigger reached
NASDAQ CYTR
CURRENT PPS
1.120
SQUEEZE TRIGGER PPS
1.094
SQUEEZE VOLUME
9,853,588
SQUEEZE VALUE
9,853,588
TOTAL SHORT INTEREST
1,222,100
SHORT % OF FLOAT
1.170
DAYS TO COVER
2.100
The reality of it all, in my opinion, is that
they wouldn't of gotten the million dollar investment
if they were going to fail. Case closed.
It will continue to hold strong in the mid teens.
Another good sign was that the short interest for last Friday
was down to about 10% of total shares traded. 59,536 shares sold short out of 586,203 Lately, it's been around 25-30%. It was nice to see that decrease on a bad market day and the 10Q risk assessment report. Overall sentiment is beginning to turn positive.
What I liked about the 10Q was that in the risk assessment, that freaked a few people out, is that the company pretty much layed it all out. They pretty much let investors know A to Z, all of risk that the company has. Most companies don't do that. They keep it to a minimum. For starters, it makes the new CEO look like a superstar when the company fixes itself. It protects the company from lawsuits from dissatisfied investors, as they get to say "We warned you.", etc, etc.
The company has a plan. They won't release pointless PRs to soothe the minds of investors who plan on selling on a nickle/dime increase. I'm sure there are a lot of people that plan on selling at .16, .18 and .22. I don't think that company is very concerned with their situation and won't release PR's to appease them. As much as they would like to bring some peace of mind to those trapped in the stock above $1 and even above .30, there's not really a realistic PR that will do that at this point in time. I doubt the company enjoys having their stock in the cellar right now. They will do whats necessary in a time frame that is best for the company. We just gotta have some patience and a whole lot of trust.
Good luck to all!